Studies related to Constipation and Lactobacillus reuteri

Prophylactic Use Of A Probiotic In The Prevention Of Colic, Regurgitation, And Functional Constipation: A Randomized Clinical Trial

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 468
Gender Both Genders
Age Range 0-1
Body Types Average
Notes for this study:
Administration of _l. reuteri_ DSM 17938 to infants during the first three months of life greatly reduced the occurrence of infantile colic relative to placebo, and also improve gastrointestinal symptoms such as increasing bowel evacuations (reducing risk of constipation) and regurgitations.

Ultimately, prophylactic treatment of infants with DSM 17938 resulted in less pediatric department visits and was estimated to save both parent and community over $200 (USD).

Full details on all 2 studies are available to Examine Plus members.